James Investment Research’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-46
Closed -$3K 504
2023
Q1
$3K Hold
46
﹤0.01% 526
2022
Q4
$2K Sell
46
-6
-12% -$277 ﹤0.01% 541
2022
Q3
$3K Hold
52
﹤0.01% 489
2022
Q2
$3K Hold
52
﹤0.01% 474
2022
Q1
$4K Hold
52
﹤0.01% 461
2021
Q4
$4K Sell
52
-4
-7% -$292 ﹤0.01% 474
2021
Q3
$4K Hold
56
﹤0.01% 459
2021
Q2
$4K Sell
56
-7
-11% -$434 ﹤0.01% 465
2021
Q1
$3K Sell
63
-104
-62% -$5.26K ﹤0.01% 459
2020
Q4
$7K Sell
167
-185
-53% -$5.97K ﹤0.01% 471
2020
Q3
$9K Hold
352
﹤0.01% 430
2020
Q2
$6K Buy
352
+5
+1% +$99 ﹤0.01% 417
2020
Q1
$5K Sell
347
-763
-69% -$21.9K ﹤0.01% 413
2019
Q4
$42K Sell
1,110
-1,454
-57% -$43.5K ﹤0.01% 403
2019
Q3
$57K Sell
2,564
-8,065
-76% -$172K ﹤0.01% 411
2019
Q2
$220K Sell
10,629
-26,158
-71% -$603K 0.02% 346
2019
Q1
$1.06M Sell
36,787
-34,669
-49% -$856K 0.07% 202
2018
Q4
$1.23M Sell
71,456
-19,807
-22% -$479K 0.08% 220
2018
Q3
$2.6M Buy
91,263
+16,177
+22% +$534K 0.11% 183
2018
Q2
$2.52M Buy
75,086
+72,196
+2,498% +$2.24M 0.1% 219
2018
Q1
$70K Buy
+2,890
New +$57.5K ﹤0.01% 630

Other funds holding THC

James Investment Research's THC Position: Q2 2023 in Review

James Investment Research sold out of Tenet Healthcare (THC) in Q2 2023, closing a stake of 46 shares — an estimated $3K sold.

James Investment Research first reported a position in THC in Q1 2018 and held it in 21 quarters. The position peaked at $2.6M in Q3 2018. 416 funds tracked by Wall St. Rank hold THC as of Q2 2023.

  • James Investment Research reported no remaining Tenet Healthcare position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 46 Tenet Healthcare shares in Q2 2023, an estimated $3K.
  • James Investment Research first reported a position in Tenet Healthcare in Q1 2018 and held it in 21 quarters.
  • James Investment Research's Tenet Healthcare position peaked at $2.6M in Q3 2018.
  • 416 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.